EXCLUSIVE: Institutional Interest In Cannabis Grows — Arcview CEO Anticipates 'Robust' M&A Activity

While a full-fledged institutional capital infusion in the cannabis industry remains on the horizon, early signs of interest are emerging.

What Happened: Speaking exclusively to Benzinga at its Cannabis Capital Conference in late-September, The Arcview Group CEO Jeffrey Finkle said that institutions are now probing, assessing, and engaging with the burgeoning sector, signaling a potential paradigm shift in investment dynamics.

He anticipates that to result in a ‘robust’ level of mergers and acquisitions (M&A) activity, and said The Arcview Group’s positioning — through their consulting arm and broker dealer partnerships — can effectively navigate and execute the expected M&A transactions.

Read also: Diverse Voices, One Industry: Cannabis Social Equity Stories, What Worked & What Didn’t

Why It Matters: Based in Oakland, California, The Arcview Group etched its mark as a pivotal player in the cannabis financing landscape.

Over a decade-long journey, The Arcview Group channeled investments into over 170 ventures spanning cannabis businesses, industrial hemp, the budding psychedelic sector, and cannabis-centric commercial real estate.

With a principal investing unit, Arcview Ventures LLC, the firm bridges high-net-worth entities and institutional investors with cannabis sector opportunities, while remaining committed to social justice and responsibility.

Read next: EXCLUSIVE: Curaleaf’s Boris Jordan Puts Premium On Cannabis Quality, Says ‘We Want To Be The Best’

Photo: Unsplash